封面
市场调查报告书
商品编码
1701111

疼痛管理设备市场规模、份额、成长分析(按产品、应用、最终用途和地区)- 2025-2032 年产业预测

Pain Management Devices Market Size, Share, and Growth Analysis, By Product (Electrical Stimulators, Radiofrequency Ablation Devices), By Application (Neuropathic Pain, Cancer Pain), By End-Use, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2023 年疼痛管理设备市场规模价值为 59.6 亿美元,预计将从 2024 年的 65.2 亿美元成长到 2032 年的 133.8 亿美元,预测期内(2025-2032 年)的复合年增长率为 9.4%。

受慢性疼痛疾病盛行率上升和技术持续创新的推动,疼痛管理设备市场正在快速成长。慢性疼痛影响全球数百万人,并已成为一项重大的医疗保健挑战,增加了对有效管理解决方案的需求。各种方法,包括电刺激、射频消融术和鞘内药物传输系统,越来越多地被认为是传统疼痛缓解方法的可行的非药物替代方法。类风湿性关节炎和癌症等疾病正在推动对持久止痛方法的需求。虽然潜在的併发症和其他风险对市场扩张构成了挑战,但技术进步正在提高这些设备的有效性和可及性,其价值也得到了患者和医疗保健专业人员的认可,从而确保了该领域的持续增长。

目录

介绍

  • 调查目的
  • 研究范围
  • 定义

调查方法

  • 资讯采购
  • 二次资料和一次资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分机会分析

市场动态与展望

  • 市场概览
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2024年)
  • PESTEL分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 案例研究
  • 技术进步
  • 监管格局

疼痛管理设备市场规模:依产品及复合年增长率(2025-2032)

  • 市场概览
  • 电刺激设备
  • 射频消融术装置
  • 止痛药输液泵
  • 神经刺激设备
  • 其他的

疼痛管理设备市场规模:按应用和复合年增长率(2025-2032)

  • 市场概览
  • 神经病变疼痛
  • 癌症痛
  • 脸部疼痛和偏头痛
  • 肌肉骨骼疼痛
  • 其他的

疼痛管理设备市场规模:依最终用途及复合年增长率(2025-2032)

  • 市场概览
  • 医院
  • 门诊手术中心
  • 居家照护
  • 其他的

疼痛管理设备市场规模:按地区及复合年增长率(2025-2032)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024年)
  • 主要企业简介
    • 公司详情
    • 产品系列分析
    • 公司分部份额分析
    • 收益与前一年同期比较对比(2022-2024 年)

主要企业简介

  • Medtronic(Ireland)
  • Boston Scientific Corporation(USA)
  • Abbott Laboratories(USA)
  • Stryker Corporation(USA)
  • Becton, Dickinson and Company(USA)
  • Baxter International Inc.(USA)
  • B. Braun SE(Germany)
  • Omron Corporation(Japan)
  • Avanos Medical, Inc.(USA)
  • Teleflex Incorporated(USA)
  • ICU Medical, Inc.(USA)
  • Nipro Corporation(Japan)
  • Moog Inc.(USA)
  • Atricure, Inc.(USA)
  • Micrel Medical Devices SA(Greece)
  • Zynex, Inc.(USA)
  • Enovis Corporation(USA)
  • Stimwave Technologies(USA)
  • SPR Therapeutics(USA)

结论和建议

简介目录
Product Code: SQMIG35A2502

Pain Management Devices Market size was valued at USD 5.96 billion in 2023 and is poised to grow from USD 6.52 billion in 2024 to USD 13.38 billion by 2032, growing at a CAGR of 9.4% during the forecast period (2025-2032).

The pain management devices market is experiencing rapid growth, driven by the rising prevalence of chronic pain conditions and ongoing technological innovations. Chronic pain, which impacts millions worldwide, has emerged as a significant healthcare challenge, enhancing the need for effective management solutions. Various methods, including electrical stimulation, radiofrequency ablation, and intrathecal drug delivery systems, are increasingly being recognized as viable non-drug alternatives to traditional pain relief approaches. Conditions like rheumatoid arthritis and cancer are propelling demand for lasting pain relief options. While risks such as potential complications pose challenges to market expansion, advancements in technology are enhancing the efficacy and accessibility of these devices, ensuring continued growth in the sector as both patients and healthcare professionals acknowledge their value.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pain Management Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pain Management Devices Market Segments Analysis

Global Pain Management Devices Market is segmented by Product, Application, End-Use and region. Based on Product, the market is segmented into Electrical Stimulators, Radiofrequency Ablation Devices, Analgesic Infusion Pumps, Neurostimulation Devices and Others. Based on Application, the market is segmented into Neuropathic Pain, Cancer Pain, Facial Pain and Migraine, Musculoskeletal Pain and Others. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgery Centers, Home Healthcare and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Pain Management Devices Market

The increasing incidence of chronic pain, particularly among the aging population, significantly drives the demand for pain management devices. Chronic pain stems from various conditions, including arthritis, cancer, and postoperative recovery, becoming increasingly prevalent and necessitating effective management solutions. As patients seek long-term pain relief without relying on opioid medications, both individuals and healthcare providers are actively exploring alternative treatment options. This shift towards non-opioid therapies is contributing to the rising adoption of pain management devices, as they offer innovative solutions to address the growing need for effective and sustainable pain relief strategies in patients' everyday lives.

Restraints in the Pain Management Devices Market

A significant challenge facing the pain management devices market is the elevated cost of these products. High-tech solutions, particularly nerve replacement devices and implant systems, often come with prohibitive price tags that can deter many patients from accessing them. The initial purchase costs are just the beginning; ongoing expenses for maintenance, repairs, and potential replacements further restrict accessibility. This issue is particularly pronounced in low to middle-income regions, where healthcare professionals may be forced to explore more affordable pain management alternatives, limiting the overall potential of advanced pain management technologies in these areas.

Market Trends of the Pain Management Devices Market

The Pain Management Devices market is witnessing a significant shift towards non-invasive solutions, driven by both patient preference and healthcare provider recommendations. Technologies such as Transcutaneous Electrical Nerve Stimulation (TENS) and innovative wearable pain management devices are gaining traction for their ability to deliver effective pain relief without the risks associated with surgical procedures or implants. This growing demand is fueled by benefits such as ease of use, a reduced likelihood of complications, and lower costs compared to invasive alternatives. As new non-invasive devices continue to enter the market, the trend is expected to persist, fundamentally reshaping pain management strategies.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Technology Advancement
  • Regulatory Landscape

Global Pain Management Devices Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Electrical Stimulators
  • Radiofrequency Ablation Devices
  • Analgesic Infusion Pumps
  • Neurostimulation Devices
  • Others

Global Pain Management Devices Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Neuropathic Pain
  • Cancer Pain
  • Facial Pain and Migraine
  • Musculoskeletal Pain
  • Others

Global Pain Management Devices Market Size by End-Use & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Ambulatory Surgery Centers
  • Home Healthcare
  • Others

Global Pain Management Devices Market Size & CAGR (2025-2032)

  • North America (Product, Application, End-Use)
    • US
    • Canada
  • Europe (Product, Application, End-Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Application, End-Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Application, End-Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Application, End-Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Medtronic (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun SE (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Omron Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avanos Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICU Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Moog Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Atricure, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Micrel Medical Devices SA (Greece)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zynex, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Enovis Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stimwave Technologies (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SPR Therapeutics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations